Published in Cochrane Database Syst Rev on October 18, 2006
What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? BMC Gastroenterol (2009) 1.24
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20
Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol (2013) 1.03
Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review. World J Gastroenterol (2014) 0.89
Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol (2014) 0.88
Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol (2010) 0.87
Clinical Management of Chronic Portal/Mesenteric Vein Thrombosis: The Surgeon's Point of View. Viszeralmedizin (2014) 0.86
Endoscopic Diagnosis and Therapy in Gastroesophageal Variceal Bleeding. Gastrointest Endosc Clin N Am (2015) 0.81
Liver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis. Transplant Proc (2010) 0.81
Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt. World J Hepatol (2016) 0.80
Management of variceal hemorrhage: current concepts. Arq Bras Cir Dig (2014) 0.79
Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis--part 3. J Gastrointest Surg (2010) 0.78
Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding. World J Gastroenterol (2012) 0.77
Percutaneous Portosystemic Shunts: TIPS and Beyond. Semin Intervent Radiol (2014) 0.75
Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. ISRN Hepatol (2013) 0.75
Transjugular intrahepatic portosystemic shunt combined with esophagogastric variceal embolization in the treatment of a large gastrorenal shunt. World J Hepatol (2016) 0.75
Current role of surgery in portal hypertension. Indian J Surg (2011) 0.75
Effects of treatment for intestinal helminth infection on growth and cognitive performance in children: systematic review of randomised trials. BMJ (2000) 7.30
A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol (1965) 5.71
New insights to the MLL recombinome of acute leukemias. Leukemia (2009) 4.07
HIV and male circumcision--a systematic review with assessment of the quality of studies. Lancet Infect Dis (2005) 3.49
Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med (1995) 3.48
Binding of -bungarotoxin to acetylcholine receptors in mammalian muscle (snake venom-denervated muscle-neonatal muscle-rat diaphragm-SDS-polyacrylamide gel electrophoresis). Proc Natl Acad Sci U S A (1972) 3.34
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut (2005) 3.32
Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J (2001) 3.22
HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature (1987) 2.96
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
A subfamily of P-type ATPases with aminophospholipid transporting activity. Science (1996) 2.90
Head-up tilt: a useful test for investigating unexplained syncope. Lancet (1986) 2.67
Randomised controlled trial of physiological and ventricular pacing. Br Heart J (1983) 2.66
Vasovagal reactions may occur after orthotopic heart transplantation. J Am Coll Cardiol (1993) 2.63
The MLL recombinome of acute leukemias in 2013. Leukemia (2013) 2.55
Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol (1991) 2.53
Functional organization of human supplementary motor cortex studied by electrical stimulation. J Neurosci (1991) 2.41
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia (2007) 2.40
Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells. Proc Natl Acad Sci U S A (2000) 2.34
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2003) 2.32
Venous graft surgery in treatment of coronary heart disease. Br Med J (1972) 2.21
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Dig Surg (2005) 2.16
Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation. Barcelona Discussion Group. Working Group on Arrhythmias of the European Society of Cardiology. Europace (1999) 2.08
National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care. Br J Obstet Gynaecol (1999) 2.06
Early and late complications after pancreatic necrosectomy. Surgery (2005) 2.03
Carotid sinus syncope treated by pacing. Analysis of persistent symptoms and role of atrioventricular sequential pacing. Br Heart J (1982) 1.98
Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther (1993) 1.96
Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol (1996) 1.92
Current standards of surgery for pancreatic cancer. Br J Surg (2004) 1.92
Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation (1986) 1.88
Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut (2004) 1.85
The physician and pharmacist team. An effective approach to cholesterol reduction. J Gen Intern Med (1997) 1.84
Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med (1999) 1.82
Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med (1998) 1.81
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia (2007) 1.79
Prognostic factors for overall survival in patients with advanced ovarian carcinoma. Ann Oncol (1991) 1.77
Heart-block following acute myocardial infarction. Treatment with demand and fixed-rate pacemakers. Lancet (1968) 1.77
Phosphatidylserine, a death knell. Cell Death Differ (2001) 1.74
Acute pancreatitis: the substantial human and financial costs. Gut (1998) 1.74
Pacemakers and defibrillators: anaesthetic implications. Br J Anaesth (2004) 1.71
Accuracy in ECG lead placement among technicians, nurses, general physicians and cardiologists. Int J Clin Pract (2007) 1.71
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer (2009) 1.69
The natural history of sick sinus syndrome. Pacing Clin Electrophysiol (1986) 1.65
Who is the patient? A family case study of a recurrent dilemma in family practice. J Fam Pract (1983) 1.63
Nocturnal cortisol, thyroid stimulating hormone, and growth hormone secretory profiles in depressed adolescents. J Am Acad Child Adolesc Psychiatry (1991) 1.60
Cervical stitch (cerclage) for preventing pregnancy loss: individual patient data meta-analysis. BJOG (2007) 1.60
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy. Br J Cancer (2007) 1.58
A scale to measure physician beliefs about psychosocial aspects of patient care. Soc Sci Med (1984) 1.57
Pacemaker syndrome. Br Med J (Clin Res Ed) (1986) 1.55
Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ (1999) 1.54
Confidential inquiry into families with two siblings with cystic fibrosis. Arch Dis Child (1997) 1.54
Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc Natl Acad Sci U S A (1986) 1.53
The conduction system in acute myocardial infarction complicated by heart block. Circulation (1968) 1.53
Pacemaker lead related tricuspid stenosis: a report of two cases. Heart (2000) 1.50
Safety of coronary arteriography. Br Heart J (1973) 1.50
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses. Br J Cancer (2008) 1.50
Permanent pacemaker implantation via the femoral vein: an alternative in cases with contraindications to the pectoral approach. Europace (2001) 1.48
Pacemaker syndrome: an iatrogenic condition. Br Heart J (1992) 1.48
Tilting towards a diagnosis in recurrent unexplained syncope. Lancet (1989) 1.47
Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia. Clin Pharmacol Ther (2007) 1.47
Respiratory changes in vasovagal syncope. J Cardiovasc Electrophysiol (2000) 1.46
The Yorkshire slide exchange external quality assessment (EQA) scheme. Cytopathology (1996) 1.45
Amnioinfusion in very early preterm prelabor rupture of membranes (AMIPROM): pregnancy, neonatal and maternal outcomes in a randomized controlled pilot study. Ultrasound Obstet Gynecol (2014) 1.45
Surface geochemistry of the clay minerals. Proc Natl Acad Sci U S A (1999) 1.45
BLOOD GROUP ACTIVITY OF GRAM-NEGATIVE BACTERIA. J Exp Med (1961) 1.44
Multiple systems for recognition of apoptotic lymphocytes by macrophages. Mol Biol Cell (1997) 1.44
'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace (2000) 1.43
Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic thymocytes. Cell Death Differ (2000) 1.42
Beliefs that foster physician avoidance of psychosocial aspects of health care. J Fam Pract (1981) 1.42
A quantitative comparison of the sensitivity of serological test for bovine brucellosis to different antibody classes. J Hyg (Lond) (1976) 1.41
Carotid sinus syncope. Int J Cardiol (1984) 1.41
How and when to investigate syncope. Br J Hosp Med (1991) 1.40
Involvement of spectrin in the maintenance of phase-state asymmetry in the erythrocyte membrane. Cell (1982) 1.40
Method of preparing emergency medicine residents for giving legal depositions. J Am Osteopath Assoc (1999) 1.39
Complications of pancreatic cancer resection. Dig Surg (2002) 1.38
The NASPE/BPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices. Pacing Clin Electrophysiol (1987) 1.37
Calcium signalling and pancreatic cell death: apoptosis or necrosis? Cell Death Differ (2007) 1.35
Minimally invasive retroperitoneal pancreatic necrosectomy. Dig Surg (2003) 1.34
Altered lipid packing identifies apoptotic thymocytes. Immunol Lett (1993) 1.33
Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation. Eur Heart J (2004) 1.32
Nucleosome structure, DNA folding, and gene activity. Cold Spring Harb Symp Quant Biol (1978) 1.32
Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood (1992) 1.30
Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J (1994) 1.28
Radioimmunoassay for antibodies against Brucella abortus: a new serological test for bovine brucellosis. J Hyg (Lond) (1976) 1.28
Is an elevated concentration of acinar cytosolic free ionised calcium the trigger for acute pancreatitis? Lancet (1995) 1.28
The cavity electrocardiogram in emergency artificial pacing. Postgrad Med J (1969) 1.27
Engulfment of apoptotic cells involves the redistribution of membrane phosphatidylserine on phagocyte and prey. Nat Cell Biol (1999) 1.27
The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. J Med Genet (1997) 1.26
Physiological cardiac pacing. Pacing Clin Electrophysiol (1980) 1.26
Randomised trial of octreotide for long term management of cirrhosis after variceal haemorrhage. BMJ (1997) 1.23
Differential expression of putative transbilayer amphipath transporters. Physiol Genomics (1999) 1.23
Merocyanine 540, a fluorescent probe sensitive to lipid packing. Biochim Biophys Acta (1983) 1.22
Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma. Dig Surg (2008) 1.22
Phospholipid asymmetry in human erythrocyte ghosts. J Cell Physiol (1985) 1.21
Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med (1995) 1.20
Binding of merocyanine 540 to normal and leukemic erythroid cells. Cell (1980) 1.19